Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06522165

Pediatric Oncological Orthopaedic Reconstruction

From the archives of the Rizzoli institute all the children undergoing oncological reconstruction from 1991 to 2023 (approximately 400 patients). A review will be made of the medical records, radiological imaging, and histological data of these patients

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

2 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Itituto Ortopedico Rizzoli

Bologna, BO, 40136, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of bone sarcoma
  • Patients with available clinical and imaging data

Exclusion criteria

  • At least one inclusion criteria not met

Treatment and study plan

Analysis

Other

analysis and review of imaging and clinical data

Primary outcomes

  1. longevity of the reconstruction

    Time frame: at baseline (day 0)

    -assess the longevity associated with pediatric oncologic reconstructions;

Secondary outcomes

  1. complications

    Time frame: at baseline (day 0)

    assess the complications associated with pediatric oncologic reconstructions;

Sponsors and collaborators

Lead sponsor

Costantino Errani

Other

Registry information

Official study title

Pediatric Oncological Orthopaedic Reconstruction : "Analysis of the Clinical and Radiographic Results"

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 26, 2024
Registry last updated
Aug 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.